Kintara Therapeutics, Inc (KTRA) PT Raised to $7 at Aegis Capital

February 3, 2021 11:22 AM EST
Get Alerts KTRA Hot Sheet
Price: $1.36 --0%

Rating Summary:
    1 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 5 | Down: 16 | New: 67
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Aegis Capital analyst Nathan Weinstein raised the price target on Kintara Therapeutics, Inc (NASDAQ: KTRA) to $7.00 (from $6.00) while maintaining a Buy rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change